Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
3,579,962
-
Share change
-
+431,293
-
Total reported value
-
$32,396,140
-
Price per share
-
$9.05
-
Number of holders
-
36
-
Value change
-
+$3,237,621
-
Number of buys
-
19
-
Number of sells
-
11
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2018
As of 30 Sep 2018,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,579,962 shares.
The largest 10 holders included
BlackRock Inc., Nantahala Capital Management, LLC, Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, P.A.W. CAPITAL CORP, Bank of New York Mellon Corp, and DEUTSCHE BANK AG\.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.